Evaluating the Scientific Evidence for Potential Reduced-Risk Tobacco Products |
| |
Biological Effects Assessment (BEA) Committee |
| |
| Meeting #3: November 29-30, 2005 |
| PRELIMINARY AGENDA |
| |
| Day One: November 29 (8 a.m. - 6 p.m.) |
| |
| |
Executive Session (8 a.m. - 6 p.m.) |
| |
I. |
Opening Remarks and Review of Agenda |
| |
II. |
Animal Models Wrap-up |
| |
III. |
Accord Case Study |
| |
|
LUNCH
|
| |
IV. |
Wrap-up of Human Biomarkers
|
| |
| |
| Day Two: November 30 (8 a.m. - 3 p.m.) |
| |
| |
Executive Session (8 a.m. - 3 p.m.) |
| |
I. |
Weight of Evidence Approaches |
| |
II. |
Integration of Cigarette Smoke Toxicants, Genotoxicity and Cytotoxicity, Animal and Human
Biomarker Data for Assessing Potential Reduced-Risk
|
| |
| |
|
LUNCH
|
| |
| |
III. |
Discussion of BEA report outline and work products
|
Adjourn (3 p.m.) |